Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-κB signaling activation in CD4+ T cells

作者: Guangwen Shu , Tianming Yang , Chaoyuan Wang , Hanwen Su , Meixian Xiang

DOI: 10.1016/J.TAAP.2013.02.019

关键词:

摘要: Gastrodia elata Blume (G. elata) is a famous restorative food in East Asia. It can be used as an auxiliary reagent hepatocellular carcinoma (HCC) treatment. Previous studies unveiled that G. exhibited immunomodulatory activities. To explore the active ingredients contributing to its activities, gastrodin, vanillin, and parishin B were purified from their anti-HCC effects assessed vivo. Among these compounds, only gastrodin was capable of repressing transplanted H22 ascitic hepatic tumor cell growth vivo with low toxicity. Further investigations designed on immune system tumor-bearing mice potential molecular mechanisms underlying effects. Our data showed ameliorated transplantation-induced activation endogenous pro-apoptotic pathway CD4+ T cells abnormalities serum cytokine profiles host animals. These events enhanced cytotoxic activities natural killer CD8+ against cancer cells. Gastrodin administration specifically upregulated mRNA levels several nuclear factor κB (NF-κB) responsive genes but not Chromatin immunoprecipitation assay increased association NF-κB p65 subunit promoter regions IL-2 Bcl-2 encoding demonstrated main ingredient anticancer properties elata. Promoting NF-κB-mediated gene transcription implicated activity.

参考文章(41)
Michael O. Hengartner, The biochemistry of apoptosis Nature. ,vol. 407, pp. 770- 776 ,(2000) , 10.1038/35037710
Kerim Çayır, Ali Karadeniz, Nejdet Şimşek, Serap Yıldırım, Emre Karakuş, Adem Kara, Hürrem Turan Akkoyun, Emin Şengül, Pomegranate seed extract attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in rats. Journal of Medicinal Food. ,vol. 14, pp. 1254- 1262 ,(2011) , 10.1089/JMF.2010.0286
Fabien Llambi, Douglas R Green, Apoptosis and oncogenesis: give and take in the BCL-2 family Current Opinion in Genetics & Development. ,vol. 21, pp. 12- 20 ,(2011) , 10.1016/J.GDE.2010.12.001
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, Jaba Gamrekelashvili, Fei Zhao, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Tim F. Greten, Firouzeh Korangy, Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor Hepatology. ,vol. 50, pp. 799- 807 ,(2009) , 10.1002/HEP.23054
Rebecca C. Taylor, Sean P. Cullen, Seamus J. Martin, Apoptosis: controlled demolition at the cellular level Nature Reviews Molecular Cell Biology. ,vol. 9, pp. 231- 241 ,(2008) , 10.1038/NRM2312
Yufeng Shi, Yan Feng, Jiuhong Kang, Chang Liu, Zhenxin Li, Dangsheng Li, Wei Cao, Ju Qiu, Zhengliang Guo, Enguang Bi, Lei Zang, Chuanzhen Lu, Jingwu Z Zhang, Gang Pei, Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nature Immunology. ,vol. 8, pp. 817- 824 ,(2007) , 10.1038/NI1489
Changsheng Du, Chang Liu, Jiuhong Kang, Guixian Zhao, Zhiqiang Ye, Shichao Huang, Zhenxin Li, Zhiying Wu, Gang Pei, MicroRNA miR-326 regulates T H -17 differentiation and is associated with the pathogenesis of multiple sclerosis Nature Immunology. ,vol. 10, pp. 1252- 1259 ,(2009) , 10.1038/NI.1798
Sorin Armeanu, Matthias Krusch, Katrin M. Baltz, Thomas S. Weiss, Irina Smirnow, Alexander Steinle, Ulrich M. Lauer, Michael Bitzer, Helmut R. Salih, Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Clinical Cancer Research. ,vol. 14, pp. 3520- 3528 ,(2008) , 10.1158/1078-0432.CCR-07-4744
Angela D. Pardee, Lisa H. Butterfield, Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities. OncoImmunology. ,vol. 1, pp. 48- 55 ,(2012) , 10.4161/ONCI.1.1.18344